Avera McKennan Hospital & University Health Center — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Avera McKennan Hospital & University Health Center appears in 16 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials16

Recruiting shown1

Roles2

SourceClinicalTrials.gov

Clinical trials

16 shown

Avera Cancer Sequencing and Analytics Protocol (ASAP)NCT05142033 · lead sponsor · 2021-11-01

Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and BreastNCT03154281 · lead sponsor · 2017-07-26

Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic OutcomesNCT02474680 · lead sponsor · 2015-11-01

Node Negative, Invasive Breast Cancer Single Fraction IOERTNCT02370797 · lead sponsor · 2015-02-01

ACTIVE_NOT_RECRUITING

Pharmacogenetic Testing on an Outpatient Population With a Depression DiagnosisNCT02443584 · lead sponsor · 2015-02-01

Pharmacogenetic Testing in an Outpatient Population of Patients With DepressionNCT02497027 · lead sponsor · 2015-02-01

Use of Metformin to Reduce Cardiac Toxicity in Breast CancerNCT02472353 · lead sponsor · 2014-07-01

Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast CancerNCT02470819 · lead sponsor · 2014-03-01

Anti-psychotic Medication (New Use) Weight Loss StudyNCT01272752 · lead sponsor · 2013-04-01

Anti-psychotic Medication (Stable Dose) Weight Loss StudyNCT01272765 · lead sponsor · 2012-03-01

Randomized Study to Evaluate the Effect of an Investigational Product on Weight Loss and Body CompositionNCT01272739 · lead sponsor · 2011-02-01

A Placebo-Controlled, Randomized, Safety and Efficacy Study to Evaluate the Change in Hemoglobin A1c Levels in Type 2 Diabetic Subjects While Taking NutralinNCT01275027 · lead sponsor · 2011-01-01

The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's DiseaseNCT01329536 · lead sponsor · 2010-12-01

A Study to Evaluate Glucose and Insulin Response to NutralinNCT01275820 · lead sponsor · 2010-06-01

Multicenter Endoscopic Sleeve Gastrectomy (ESG) Trial (MERIT Trial)NCT03406975 · collaborator · 2017-12-20

Intra-Operative Electron Boost and Hypofractionated Whole-Breast Irradiation During Breast-conserving Treatment (BCT)NCT01343459 · collaborator · 2011-01-01

Drugs studied in this sponsor's trials

4 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Avera McKennan Hospital & University Health Center as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

doxorubicin1

everolimus1

metformin1

niraparib1

doxorubicin RxCUI 3639 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial everolimus RxCUI 141704 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial metformin RxCUI 6809 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial niraparib RxCUI 1918231 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor14

collaborator2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.